SGP
SpyGlass Pharma, Inc.
34.97
+0.79 (+2.31%)
52w low 17.06
39.92 high
78.3% of range
Financial Analysis
| (USD) | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|
| Cash & Equivalents | 106.01M | 96.36M | 238.90M | 223.14M | |
| Receivables | 418.01K | 431.00K | 653.00K | 678.00K | |
| Current Assets | 119.70M | 108.77M | 253.36M | 236.46M | |
| Net PP&E | 5.13M | 3.89M | 4.24M | 6.21M | |
| Total Assets | 127.01M | 115.87M | 258.39M | 243.43M | |
| Current Liabilities | 6.61M | 8.58M | 6.67M | 9.44M | |
| Total Debt | 3.57M | 1.58M | 1.61M | 1.63M | |
| Total Liabilities | 214.24M | 214.70M | 8.27M | 11.07M | |
| Retained Earnings | -92.18M | -104.73M | -118.55M | -138.41M | |
| Shareholders Equity | -87.22M | -98.84M | 250.11M | 232.36M | |
| Working Capital | 113.09M | 100.18M | 246.69M | 227.02M | |
| Shares Outstanding | 31.91M | 31.91M | 33.43M | 33.45M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--